IP Library Granted Patent US 7,276,337
Granted Patent B2
US 7,276,337 · App. 10/694,480 · Granted Oct 2, 2007

Compositions and methods for visual ribonuclease detection assays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,276,337
App. No.
10/694,480
Granted
Oct 2, 2007
Kind
B2
Abstract

The present invention relates to methods for detecting the presence of ribonuclease enzymes, more specifically to methods that provide for a visual detection assay. The methods entail contacting a test sample suspected of containing ribonuclease activity with a substrate containing a ribonuclease-sensitive internucleotide linkage flanked directly or indirectly by a fluorescence reporter group and a dark quencher, such that if a ribonuclease activity is present in the sample, the ribonuclease-sensitive internucleotide linkage is cleaved and the fluorescence reporter group emits a visually detectable signal. The present invention further provides novel nucleic acid compositions used as substrates for such assays and encompasses kits for performing the methods of the invention.

Claims (9)

1. A nucleic acid, comprising:

(a) an enzymatic cleavage domain comprising a formula: 5′-N 1 -n-N 2 -3′, wherein:

(i) “N 1 ” represents zero to five 2′-modified ribonucleotide residues:

(ii) “N 2 ” represents one to five 2′-modified ribonucleotide residues; and

(iii) “n” comprises the sequence “auggc”;

(b) a fluorescence reporter group on one side of an internucleotide linkage; and

(c) a non-fluorescent fluorescence-ciuenching group on a side of the internucleotide linkage opposite the fluorescence reporter group.

2. The nucleic acid of claim 1 , wherein N 1 and N 2 each represent one 2′-modified ribonucleotide residue.

3. The nucleic acid of claim 2 , wherein the 2′-modified ribonucleotide residue is an adenosine.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2017
From: JPMORGAN CHASE BANK, N.A.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 043800/0186 →